Indo-MIM Listing: Opened at ₹700, a 44% Pop — and the GMP Undershot

When we covered Indo-MIM before it listed, it carried the highest grey market premium on the board — about ₹184, or 38% over its ₹485 issue price. The obvious question with any hyped issue is whether that number survives contact with the exchange.

It did — and then some. Here is the actual result, checked against what the grey market had predicted.

What actually happened

Indo-MIM listed on 30 July 2026 and opened at ₹700, against an issue price of ₹485 (the top of the ₹461–485 band). That is a listing gain of about 44%. It did not fade on debut either — as of writing the stock was around ₹741.75, above the listing price.

The demand behind that was real: the issue was subscribed about 72 times, a ₹3,812 crore mainboard offering with an order book far larger than the shares on sale.

GMP said 38%. The stock did 44%.

This is the part worth sitting with, because it is the opposite of the usual warning about grey market premium.

The grey market was right about the direction and conservative on the number. GMP implied roughly +38%; the stock opened around +44% and kept going. That does happen — but it is not the pattern to bank on, which is exactly why one strong result is not a rule.

We keep a running, unemotional record of this. In our study of every listing against its GMP, the finding was that GMP is directionally useful and precisely unreliable — it is usually right about premium-versus-discount, and it misses the exact number in both directions. Indo-MIM is a clean example of it missing on the happy side. Plenty of others miss the other way.

What one lot returned

The maths, in plain rupees, for a single retail lot at the cut-off price:

• Lot size: 30 shares
• Applied at: ₹14,550 (30 × ₹485)
• Value at the ₹700 open: ₹21,000
• Listing-day gain: about ₹6,450 per lot, on paper, before brokerage and taxes

At the current ~₹741.75, that lot is worth about ₹22,252 — a gain of roughly ₹7,700 over the application amount. Paper gains, and only for those who were actually allotted; at 72× subscription, most applicants were not.

The honest caveats

One listing is not evidence of anything. GMP undershooting here says nothing about the next issue. The value of tracking listings is in the distribution across many of them, not in the one that went well.

The pop is not the business. A 44% debut tells you about demand and pricing, not about whether Indo-MIM is a good long-term holding. Those are different questions, and the second one needs the financials, not the tape.

Allotment was the real hurdle. On a 72× subscribed book, the gain only mattered to the minority who received shares. For everyone else the return was zero, regardless of how the stock opened.

The short version

Indo-MIM opened at ₹700 — a 44% pop on a ₹485 issue — and has held above that. The grey market called the direction and slightly under-shot the size, for once. Enjoy the data point, but keep it as one line in a long table, not a lesson that GMP is now trustworthy.

You can see the live price and the full timeline on the Indo-MIM IPO page, and browse other recently listed IPOs to see how their debuts compared to expectations.

Nothing here is investment advice. GMP is an unofficial indicator and we are not SEBI-registered analysts. Listing gains are on paper, apply only to allotted shares, and are before brokerage and taxes. Prices change — verify the live figure before acting.